Guideline and Recommendations 2023 Clinical Practice Guideline The 2023 guideline contains 25 recommendations and 10 good practice statements with a focus on exercise, nutrition, fracture risk assessment, treatment and more […]

Bone Health 101 What you need to know about your bone health Did you know at least 1 in 3 women and 1 in 5 men will suffer from an osteoporotic fracture […]

About Us Educate, empower and support Who Are We Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals […]

2010 Clinical Practice Guidelines Additional Osteoporosis Guidelines Resources 2010 Clinical Practice Guidelines Access the CMAJ publication. READ THE PUBLICATION 2010 Clinical Practice Guidelines Technical Report Access the Technical Report. READ […]

Vitamin D supplementation has recently been evaluated in Switzerland in a small 1 year randomized clinical trial by Bischoff-Ferrari and colleagues. This study compared the effects of two “high” doses […]

The National Osteoporosis Foundation and the American Society for Preventive Cardiology formed an expert panel and completed a detailed review of all published research evaluating the effects of calcium intake […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

DIAGNOSIS The importance of a comprehensive fracture risk assessment Insist on Assessment Osteoporosis often goes undiagnosed until a bone fractures, and is therefore commonly referred to as “the silent thief”. […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]